ACSL4 and breast carcinoma: The non-S-palmitoylation form of MTDH-CS enhanced the interaction between MTDH and the ferroptosis enhancer of Acyl-CoA synthetase long-chain family member 4 (ACSL4), thereby reducing ferroptosis sensitivity in breast cancer cells.